Immunology and Microbiology
Yersinia
100%
Secretion (Process)
95%
Yersinia enterocolitica
87%
Gene
58%
Bacterium
42%
Eukaryotic Cell
40%
Macrophage
28%
Virulence
27%
Host
24%
Mutant
24%
Plasmid
23%
Type Three Secretion System
23%
Cells
22%
Capnocytophaga
20%
Host Cell
20%
Cytosol
18%
Operon
18%
LcrV
18%
Cell Membrane
17%
Dog
15%
Species
15%
Surface Property
15%
Target Cell
14%
Serotype
14%
Escherichia coli
13%
Membrane
13%
Mouse
13%
Gram-Negative Bacteria
12%
Virulence Plasmid
11%
Amino Terminal Sequence
11%
Hybrid
11%
Length
10%
Infectious Agent
9%
Phagocytosis
9%
Antigen
9%
Outer Membrane
9%
Mutation
9%
Transcriptional Activator
8%
Plant
8%
Pathogenicity
8%
Immune Response
7%
Promoter Region
7%
Chromosome
7%
Regulon
7%
Human
7%
Prevalence
7%
Temperature
6%
Cholera Toxin
6%
Cytoskeleton
6%
Enteropathogenic Escherichia Coli
6%
Biochemistry, Genetics and Molecular Biology
Protein
97%
Yersinia enterocolitica
79%
Secretion (Process)
73%
Yersinia
69%
Host
42%
Nested Gene
40%
Bacterium
31%
Capnocytophaga
28%
Mutant
27%
Cell Membrane
17%
Macrophage
16%
Surface Property
15%
Virulence
15%
LcrV
14%
Length
13%
N-Terminus
12%
Dog
12%
Type III Secretion System
11%
Hybrid
10%
Genetics
10%
Species
9%
Mutation
9%
Infectious Agent
9%
Human
9%
Mouse
9%
Enzyme Specificity
8%
Membrane
7%
Polysaccharide
7%
Experiment
7%
Regulatory Mechanism
7%
Nucleotide Sequence
7%
Molecule
6%
Outer Membrane
6%
Lipid A
6%
Escherichia coli
6%
Serotype
6%
Calcium
6%
Contrast
6%
Basal Body
6%
Virulence Plasmid
6%
Deglycosylation
6%
Gene Fusion
6%
Operon
6%
Channel Gating
5%
Crystal Structure
5%
Outer Membrane Protein
5%
Internalization
5%
Secretory Pathway
5%
Inner Membrane
5%
Restriction Map
5%
Medicine and Dentistry
Protein
38%
Secretion (Process)
37%
Yersinia
25%
Yersinia enterocolitica
21%
Bacterium
20%
Gene
15%
Eukaryotic Cell
15%
Type Three Secretion System
14%
Cells
12%
Host
11%
Cell Membrane
9%
Host Cell
9%
Capnocytophaga
9%
Gram-Negative Bacteria
8%
Target Cell
8%
Calcium Ion
8%
Cytosol
7%
Inner Membrane
6%
T Lymphocyte
6%
Infection
6%
Virulence
5%
Peptide
5%
Combination Therapy
5%
Mutant
5%
Toxin
5%
Septicemia
5%
In Vitro
5%
Comprehension
5%
Immune System
5%
Amino Terminal Sequence
5%